arbekacin has been researched along with novobiocin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ariga, H; Tanaka, N; Yamaki, H | 1 |
Adachi, H; Akamatsu, Y; Hashizume, H; Igarashi, M; Nishimura, Y | 1 |
2 other study(ies) available for arbekacin and novobiocin
Article | Year |
---|---|
Inhibition of SV40 DNA replication in vitro by 1-N-acyl-3"-N-(trifluoroacetyl) kanamycin.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Antiviral Agents; Aphidicolin; Deoxycytidine Monophosphate; Dibekacin; Diterpenes; DNA Replication; DNA, Viral; Haplorhini; Hygromycin B; Kanamycin; Nalidixic Acid; Novobiocin; Simian virus 40; Spectrophotometry; Streptomycin | 1986 |
Biological activities of pargamicin A, a novel cyclic peptide antibiotic from Amycolatopsis sp.
Topics: Actinomycetales; Anti-Bacterial Agents; Cell Membrane; Dibekacin; Enterococcus faecalis; Fluorescent Dyes; Membrane Potentials; Microbial Sensitivity Tests; Novobiocin; Peptides, Cyclic; Staphylococcus aureus; Vancomycin | 2010 |